Medicina Webinar | Onco-Surgical Approach to Peritoneal Malignancies — When, How, and to Whom?
Medicina Webinar | Onco-Surgical Approach to Peritoneal Malignancies — When, How, and to Whom?
Part of the MDPI Medicina Webinars series
28 January 2026
cytoreductive surgery, HIPEC, peritoneal metastases, colorectal cancer, ovarian cancer, pseudomyxoma peritonei, mesothelioma
Welcome from the Chairs
10th Medicina Webinar
Onco-Surgical Approach to Peritoneal Malignancies — When, How, and to Whom?
Dear colleagues,
It is an honor for us to host this webinar, titled “Onco-surgical approach to peritoneal malignancies—when, how, and to whom?”, on behalf of Medicina.
This webinar aims to offer a comprehensive overview of surgical procedures intending to cure both primary peritoneal malignancies and peritoneal metastases (mainly from ovarian and digestive cancers). Since these patients need a multidisciplinary approach to significantly prolong their lives, experienced surgeons and oncologists will join this meeting to discuss the updates in onco-surgical management of these patients. Beyond current therapeutic standards, the speakers will present updated evidence about unresolved issues such as the use of HIPEC, the optimal extent of cytoreductive surgery, its specific indications, and the best timing of the surgery with respect to systemic chemotherapy.
This webinar is addressed not only to surgeons and oncologists, but also to the gastroenterologists, gynecologists, pathologists, and general practitioners, because the recent advances in this field have dramatically improved the survival of such patients considered until recently as candidates for palliative therapy alone.
Date: 28 January 2025
Time: 4:00 PM CET | 10:00 AM EDT | 11:00 PM CST (Asia)
Webinar ID: 898 3237 0697
Webinar Secretariat: journal.webinar@mdpi.com
Event Chair
1. Department of Hepato-Bilio-Pancreatic Surgery, Emergency University Hospital, Bucharest, Romania
2. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Dr. Alexandrescu is a consultant in General Surgery, specializing in HPB Surgery as well as in Oncologic Surgery. Presently, he is the head of the HPB Surgery Department at the Emergency University Hospital, Bucharest, Romania. He has performed more than 2000 procedures for digestive cancers, almost half of them being colorectal resections. Consequently, he has performed hundreds of liver resections for colorectal liver metastases and treated many patients with peritoneal metastases of colorectal origin. Because of the favorable outcomes reported with cytoreductive surgery (CRS) in such patients during the last decade and thanks to his experience achieved in almost 100 procedures for advanced ovarian cancer, during the last few years, he has also developed a special interest in the surgical approach to colorectal peritoneal metastases. Of the almost 150 papers he has published, more than 25 are dedicated to the topic of colorectal metastases, either hepatic or peritoneal.
1. Department of Oncology, Fundeni Clinical Institute, Bucharest, Romania
2. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Dr. Adina Croitoru is a medical oncologist at Fundeni Clinical Institute, Bucharest, Romania, and a Professor at Carol Davila University of Medicine and Pharmacy, Bucharest, with over 25 years of experience in oncology and a special clinical focus on digestive cancers. She is actively involved in research and international clinical trials and is the author of numerous scientific publications and conference presentations. She is also a member of the European Neuroendocrine Tumor Society (ENETS) Advisory Board. She is engaged in the medical education and training of young oncologists and participates regularly in national and international conferences. She is committed to advancing knowledge and patient care in oncology.
1. Department of Surgical Oncology, Cancer Institute Montpellier, University of Montpellier, Montpellier, France
2. IRCM, Institut De Recherche en Cancérologie de Montpellier, Inserm U1194 Department, Université De Montpellier, Institut Régional Du Cancer De Montpellier, Montpellier, F-34298, France
Dr. Olivia Sgarbura is a chief consultant in surgical oncology at the Montpellier Cancer Institute in France. Her clinical and research activity is focused on peritoneal and liver metastases, with a high yearly volume of cytoreductive procedures. In the treatment of peritoneal malignancies, she is experienced with various techniques such as HIPEC, PIPAC, and IP. She is the principal investigator of a phase I (NIPOX) and a phase II randomized trial (MESOTIP) and an associated investigator in many other trials. She was appointed ESPSO (European School of Peritoneal Surface Oncology) mentor after being an international trainer in cytoreductive surgery, HIPEC, and PIPAC on different continents. She currently serves as the vice-president of the SFCO (Francophone Society of Surgical Oncology) and a board member of RENAPE (French National Network of Peritoneal Malignancies) and of the Educational and Training Committee of ESSO. She is the recipient of the Surgical Society of Oncology (SSO) career development exchange award for 2020.
Keynote Speakers
1. Department of Surgical Oncology, Cancer Institute Montpellier, University of Montpellier, Montpellier, France
2. IRCM, Institut De Recherche en Cancérologie de Montpellier, Inserm U1194 Department, Université De Montpellier, Institut Régional Du Cancer De Montpellier, Montpellier, F-34298, France
Updates in Onco-Surgical Management of Primary Peritoneal Tumors
Dr. Olivia Sgarbura is a chief consultant in surgical oncology at the Montpellier Cancer Institute in France. Her clinical and research activity is focused on peritoneal and liver metastases, with a high yearly volume of cytoreductive procedures. In the treatment of peritoneal malignancies, she is experienced with various techniques such as HIPEC, PIPAC, and IP. She is the principal investigator of a phase I (NIPOX) and a phase II randomized trial (MESOTIP) and an associated investigator in many other trials. She was appointed ESPSO (European School of Peritoneal Surface Oncology) mentor after being an international trainer in cytoreductive surgery, HIPEC, and PIPAC on different continents. She currently serves as the vice-president of the SFCO (Francophone Society of Surgical Oncology) and a board member of RENAPE (French National Network of Peritoneal Malignancies) and of the Educational and Training Committee of ESSO. She is the recipient of the Surgical Society of Oncology (SSO) career development exchange award for 2020.
1. Department of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania
2. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Updates in Onco-Surgical Management of Peritoneal Metastases of Ovarian Cancer
Dr. Gheorghe Potlog is a General Surgery Specialist and PhD student at the Department of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania. He has participated in more than 100 cytoreductive procedures, including HIPEC, in the management of advanced ovarian cancer and peritoneal carcinomatosis. His doctoral research focuses on “HIPEC—a translational approach between past and future in the personalized treatment of digestive and gynecological cancers.” In 2023, Dr. Potlog completed a clinical observership at the Center for General and Visceral Surgery at Krankenhaus Barmherzige Brüder, Regensburg, Germany, under the supervision of Prof. Dr. med. Dr. h. c. Pompiliu Piso. He has an active interest in peritoneal surface malignancies and has participated in various international surgical conferences, including meetings of the Peritoneal Surface Oncology Group International (PSOGI).
1. Department of Hepato-Bilio-Pancreatic Surgery, Emergency University Hospital, Bucharest, Romania
2. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Updates in Onco-Surgical Management of Peritoneal Metastases of Gastrointestinal Malignancies
Dr. Razvan Grigorie is a consultant in General Surgery, with a specialization in oncologic, hepatobiliary, and liver transplantation surgery, and he has participated in and performed a variety of surgical interventions on oncological cases. These include cases of peritoneal carcinomatosis primarily originating from digestive and ovarian cancers, as well as rare instances of primary peritoneal cancers or goblet cell carcinoma. He has also conducted numerous liver resections for liver metastases, predominantly from colorectal cancers. In select cases, the consultant has extended the boundaries of surgical intervention to include oligometastatic liver involvement in gastric or pancreatic cancer, and certain colorectal cancer cases with limited peritoneal carcinomatosis amenable to CCR0 resection. Additionally, the consultant has performed and attended numerous liver transplantation procedures, many of which were indicated for oncological reasons such as hepatocellular carcinoma and rare cases of hemangioendothelioma. The consultant has a specific interest in minimally invasive surgery and is keenly interested in clinical and translational research as well as medical education.
Registration
This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.
Program
| Speaker/Presentation | Time in CET |
|
Olivia Sgarbura, Adina Croitoru, Sorin Alexandrescu Chair Introduction |
4:00 - 4:10 pm |
|
Olivia Sgarbura Updates in Onco-surgical Management of Primary Peritoneal Tumors |
4:10 - 4:30 pm |
|
Gheorghe Potlog Updates in Onco-surgical Management of Peritoneal Metastases of Ovarian Cancer |
4:30 - 4:50 pm |
|
Razvan Grigorie Updates in Onco-surgical Management of Peritoneal Metastases of Gastrointestinal Malignancies |
4:50 - 5:10 pm |
| Q&A | 5:10 - 5:25 pm |
|
Sorin Alexandrescu, Olivia Sgarbura, Adina Croitoru Closing of Webinar |
5:25 - 5:30 pm |
Sponsors and Partners
Organizers
